loading
Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.132
 - 0.13 0.076 0.173
Operating Expenses
12.65
 - 12.68 10.80 13.40
Benefits Costs and Expenses
12.29
 - 10.37 9.329 14.18
Costs And Expenses
12.29
 - 10.37 9.329 14.18
Operating Income/Loss
-12.52
 - -12.55 -10.72 -13.23
Income/Loss From Continuing Operations Before Tax
159.56%
-12.16
 -4.684 -10.23 -9.253 -14.01
Income Tax Expense/Benefit
-
 - - - -
Income/Loss From Continuing Operations After Tax
159.56%
-12.16
 -4.684 -10.23 -9.253 -14.01
Net Income/Loss
159.56%
-12.16
 -4.684 -10.23 -9.253 -14.01
Preferred Stock Dividends And Other Adjustments
-
 - - - -
Attributable To Noncontrolling Interest
-
 - - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
 - - -0.458 -

Simile a OVID

biotechnology RPRX
$45.65
price down icon 0.48%
biotechnology ROIV
$28.06
price down icon 1.72%
biotechnology MRNA
$52.56
price down icon 1.55%
biotechnology BNTX
$91.19
price up icon 1.21%
biotechnology INSM
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):